MedTrace Logo

Interference and Stability Evaluation of the Intelligent Fingerprinting Drug Screening System

NCT07758907 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2026-08-11

No results posted yet for this study

Summary

Prospective, open-label, double-dose, performance evaluation of interference effects and component stability of the Intelligent Fingerprinting Drug Screening System

Conditions

  • Interference With Routine Analytical Tests
  • Stability of in Vitro Diagnostic Reagents
  • Illicit Drug Use

Interventions

DEVICE

Device storage condition

Device will be stored prior to and following sample collection.

DEVICE

Interferent application

Interferent will be applied to subjects' fingers prior to measurement of drug in fingerprint sweat.

Sponsors & Collaborators

  • CenExel

    collaborator UNKNOWN

  • Intelligent Bio Solutions Inc.

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-15
Primary Completion
2026-08-31
Completion
2026-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07758907 on ClinicalTrials.gov